Eagle Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference

December 23, 2019 Off By BusinessWire

WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference as follows:

Date:

Wednesday, January 15, 2020

 

Time:

4:00 p.m. Pacific Standard Time

 

Location:

Westin St. Francis Hotel, San Francisco

 

Webcast:

https://jpmorgan.metameetings.net/events/hc20/sessions/29767-eagle-pharmaceuticals/webcast

 

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing innovative and differentiated injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Additional information is available on the Company’s website at www.eagleus.com.

Contacts

Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson

In-Site Communications, Inc.

T: 212-452-2793

E: [email protected]